Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers - Lung Cancer
Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival - ScienceDirect
PT 3: Oncology: Lung Cancer Pharmacotherapy (EXAM 10) Flashcards | Quizlet
Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non‑small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis
P2.17-02 Survival in Performance Status 3 Non-Small Cell Lung Cancer Patients Receiving Radical Radiotherapy - Journal of Thoracic Oncology
Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab | Scientific Reports
Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy - Physics and Imaging in Radiation Oncology
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) | SpringerLink
PDF) role of chemotherapy in PS3 Small cell lung cancer
Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status - Adachi - 2020 - Cancer Medicine - Wiley Online Library
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR) - ESMO Open
Cutting-edge Medical Treatment for Advanced Non-small Cell Lung Cancer
Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales - Lung Cancer
The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment - Sueoka‐Aragane - - Cancer Medicine - Wiley Online Library
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Clinical Outcomes After First-line EGFR Inhibitor Treatment for Patients with NSCLC, EGFR Mutation, and Poor Performance Status | Anticancer Research
Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer - Clinical Lung Cancer
Epidemiology of lung cancer - ppt download
Stage 3 Lung Cancer: Survival Rate, Prognosis, and More
Early mortality in lung cancer: French prospective multicentre observational study – topic of research paper in Health sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors - Clinical Lung Cancer
Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research - ScienceDirect
Stage 3 Lung Cancer: Prognosis, Life Expectancy, Treatment, and More
